Dover Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Dover Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.95M	Sell	3,962 -263	-6%	-$143K	0.81%	36
2025 Q4	$2.45M	Buy	4,225 +155	+4%	+$87.7K	0.95%	28
2025 Q3	$1.98M	Buy	4,070 +6	+0.1%	+$2.79K	0.79%	38
2025 Q2	$1.65M	Sell	4,064 -271	-6%	-$113K	0.73%	41
2025 Q1	$2.16M	Buy	4,335 +607	+16%	+$329K	0.94%	32
2024 Q4	$1.94M	Buy	3,728 +59	+2%	+$32.4K	1.11%	25
2024 Q3	$2.27M	Buy	3,669 +212	+6%	+$125K	1.29%	19
2024 Q2	$1.91M	Hold	3,457	–	–	1.18%	22
2024 Q1	$2.01M	Buy	3,457 +1,117	+48%	+$627K	1.38%	20
2023 Q4	$1.24M	Sell	2,340 -852	-27%	-$412K	1.63%	17
2023 Q3	$1.62M	Buy	3,192 +24	+0.8%	+$12.8K	1.64%	16
2023 Q2	$1.65M	Buy	3,168 +20	+0.6%	+$10.8K	1.47%	19
2023 Q1	$1.82M	Buy	3,148 +379	+14%	+$214K	1.75%	14
2022 Q4	$1.53M	Buy	+2,769	New	+$1.47M	1.65%	14

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dover Advisors's TMO Position: Q1 2026 in Review

Dover Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.2% in Q1 2026, selling an estimated $143K and leaving 3,962 shares worth $1.95M. The position accounts for 0.81% of the portfolio, ranked #36.

Dover Advisors first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.45M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Dover Advisors held 3,962 shares of Thermo Fisher Scientific worth $1.95M as of Q1 2026.
Dover Advisors sold 263 Thermo Fisher Scientific shares in Q1 2026, an estimated $143K.
Thermo Fisher Scientific made up 0.81% of Dover Advisors's portfolio in Q1 2026, its #36 holding.
Dover Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
Dover Advisors's Thermo Fisher Scientific position peaked at $2.45M in Q4 2025.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Dover Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.